Zentalis
The Director of Regulatory Affairs – Labeling will lead the global product labeling function, shaping and implementing labeling strategies across the product lifecycle and ensuring compliance with regulatory expectations. This contract role involves partnering with cross‑functional teams, managing labeling documentation, and serving as a subject‑matter expert on regulatory labeling requirements.
Zentalis Pharmaceuticals is a clinical-stage oncology company focused on developing azenosertib, a first-in-class oral WEE1 kinase inhibitor, for Cyclin E1-positive platinum-resistant ovarian cancer and other tumor types. The company is advancing azenosertib through late-stage, registration-intended clinical trials, including the Phase 3 ASPENOVA trial, using a biomarker-directed approach to provide a non-chemotherapy targeted therapy option. Zentalis engages the investor and medical communities through detailed pipeline, financial, and governance resources from its headquarters in San Diego, CA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zentalis.
33% above the average for this role
Regulatory Affairs Manager - Labeling
Cardinal Health
Manager, Regulatory Affairs – Global Labeling
GE HealthCare
Sr. Dir. Regulatory Affairs, Head of Global Labeling and Labeling Operations
argenx
Principal Regulatory Affairs Specialist, Labeling (SWICC)
Getinge
Manager, Regulatory Affairs (Clinical Labeling)
Telix Pharmaceuticals
Manager, Regulatory Affairs – Global Labeling, PDx
lifelancer